Were Hedge Funds Right About TCR2 Therapeutics Inc. (TCRR)?
A whopping number of 13F filings filed with U.S.
Tcr2 Therapeutics Inc. (TCRR)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Long Focus Capital Management John B. Helmers | 0 | $0 | 0% | |
| 2. | Redmile Group Jeremy Green | 0 | $0 | 0% | |
| 3. | Baker Bros. Advisors Julian Baker And Felix Baker | 0 | $0 | 0% | |
| 4. | Millennium Management Israel Englander | 0 | $0 | 0% | |
| 5. | Newtyn Management Noah Levy And Eugene Dozortsev | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 50,000 | $86,000.00 | 4,394,800 | 2023-05-25 | Filing | |
| $1.95 | 6,183 | $12,056.85 | 4,344,800 | 2023-05-12 | Filing | |
| $1.95 | 38,765 | $75,591.75 | 4,338,617 | 2023-05-11 | Filing | |
| $1.95 | 6,774 | $13,209.30 | 4,299,852 | 2023-05-10 | Filing | |
| $1.95 | 20,141 | $39,274.95 | 4,293,078 | 2023-05-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.88 | 70,170 | $131,919.60 | 304,001 | 2023-05-22 | Filing | |
| $1.88 | 70,170 | $131,919.60 | 304,001 | 2023-05-22 | Filing | |
| $1.06 | 4,752 | $5,041.87 | 109,459 | 2022-12-13 | Filing | |
| $1.10 | 4,586 | $5,040.01 | 114,211 | 2022-12-12 | Filing | |
| $1.13 | 4,461 | $5,040.93 | 118,797 | 2022-12-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 0 | $0 | 0% | |
| 2. | 0 | $0 | 0% | |
| 3. | 0 | $0 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 0 | $0 | 0% |
News See All
Is TCRR A Good Stock To Buy Now?
In this article you are going to find out whether hedge funds think TCR2 Therapeutics Inc. (NASDAQ:TCRR) is a good investment right now.
Hedge Funds Have Never Been This Bullish On TCR2 Therapeutics Inc. (TCRR)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Is TCR2 Therapeutics Inc. (TCRR) A Good Stock To Buy ?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Billionaire Hedge Funds
